Japan
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 17.47 B |
Jan. 31, 2025 | USD 9.76 | -1.53% |
|
Japan |
|
2 |
USD 12.55 B |
Jan. 31, 2025 | USD 14.75 | -0.46% |
|
Japan |
|
3 |
USD 3.45 B |
Jan. 31, 2025 | USD 10.09 | 0.15% |
|
Japan |
|
4 |
USD 1.79 B |
Jan. 31, 2025 | USD 13.83 | -0.63% |
|
Japan |
|
5 |
USD 1.09 B |
Jan. 31, 2025 | USD 25.51 | -0.96% |
|
Japan |
|
6 |
USD 434.06 M |
Jan. 31, 2025 | USD 3.56 | -3.55% |
|
Japan |
|
7 |
USD 219.03 M |
Jan. 31, 2025 | USD 11.15 | -1.27% |
|
Japan |
|
8 |
USD 185.94 M |
Jan. 31, 2025 | USD 9.76 | -1.43% |
|
Japan |
|
9 |
USD 83.26 M |
Jan. 31, 2025 | USD 3.68 | -3.46% |
|
Japan |
|
10 |
USD 63.68 M |
Jan. 31, 2025 | USD 0.90 | -0.59% |
|
Japan |
|
11 |
USD 55.51 M |
Jan. 31, 2025 | USD 1.21 | 1.57% |
|
Japan |
|
12 |
USD 55.49 M |
Jan. 31, 2025 | USD 2.56 | -2.54% |
|
Japan |
|
13 |
USD 45.51 M |
Jan. 31, 2025 | USD 0.17 | -10.87% |
|
Japan |
|
14 |
USD 26.97 M |
Jan. 31, 2025 | USD 1.03 | -3.60% |
|
Japan |
|
15 |
USD 23.63 M |
Jan. 31, 2025 | USD 0.28 | -0.59% |
|
Japan |
The Vaccines company in Japan with the highest Market Capitalization is Astellas Pharma Inc. (Tokyo Stock Exchange: 4503.T) at USD 17.47 B.
The Vaccines company in Japan with the lowest Market Capitalization is BrightPath Biotherapeutics Co., Ltd. (Tokyo Stock Exchange: 4594.T) at USD 23.63 M.
The top 10 Vaccines companies in Japan by Market Capitalization are Astellas Pharma Inc., Shionogi & Co., Ltd., Santen Pharmaceutical Co., Ltd., PeptiDream Inc., Kissei Pharmaceutical Co., Ltd., JCR Pharmaceuticals Co., Ltd., WDB Holdings Co., Ltd., Mizuho Medy Co.,Ltd., Oncolys BioPharma Inc. and NanoCarrier Co., Ltd..
The bottom 10 Vaccines companies in Japan by Market Capitalization are BrightPath Biotherapeutics Co., Ltd., Soiken Holdings Inc., OncoTherapy Science, Inc., RaQualia Pharma Inc., SymBio Pharmaceuticals Limited, NanoCarrier Co., Ltd., Oncolys BioPharma Inc., Mizuho Medy Co.,Ltd., WDB Holdings Co., Ltd. and JCR Pharmaceuticals Co., Ltd..